The Importance of Demonstrating & Communicating Value of Your Drug Candidate

Time: 8:30 am
day: Day Two


  • Debating how we present a case for reimbursement on life-limiting versus life-threatening disease
  • Considering a multistakeholder perspective when communicating the value of your product
  • Debating at which stage of drug development to begin thinking about/integrating the patient perspective
  • Exploring quality of life surveys in clinical trials
  • Patient-reported Outcomes: how do they vary between diseases?